Status:
ACTIVE_NOT_RECRUITING
Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This project will study and characterize Microplastic (MP) burden in the lungs of patients undergoing Bronchoalveolar Levage (BAL) in thoracic clinics at Moffitt.
Eligibility Criteria
Inclusion
- English or Spanish-speaking patients scheduled for bronchoscopy/bronchoalveolar lavage (BAL) in thoracic clinics at Moffitt.
Exclusion
- Patients with a known prior history of lung cancer or that have undergone a Bronchoalveolar Lavage (BAL) procedure at any time in the past in the involved lung targeted for BAL.
- Patients that have had any prior lung or thoracic or surgeries or procedures (examples: removal of lung or portions of the involved lung (lobectomy, pneumonectomy, wedge resection/segmentectomy).
- Patients with specimens that are considered to be non-adequate as true Bronchoalveolar Lavage Fluid (BALF) (i.e., absence of alveolar macrophages) after pathologist's evaluation will be excluded from the study.
Key Trial Info
Start Date :
February 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 18 2026
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT06530615
Start Date
February 5 2024
End Date
September 18 2026
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moffitt Cancer Center
Tampa, Florida, United States, 33612